On the basis of these results, we propose that patients with NMO/NMOSD who carry MOG-ab, but not AQP4-ab, exhibit an intermediate disease phenotype of classical NMO and relapsing MS, which was consistent with Pröbstel’s group study (Marta et al., 2005). The gene discussed is AQP4; the disease is neuromyelitis optica.